ESR1 and breast cancer: Here, we propose a culture strategy in which patient-derived tissue microstructures retain ER+ carcinoma cells for at least 1 month of culture; of note, these cells still respond to ER stimulation and inhibition, therefore constituting a functional ex vivo model of ER-positive BC.